Department of Pharmacy, Rhode Island Hospital, Providence, RI 02903, USA.
Int J Qual Health Care. 2011 Feb;23(1):36-43. doi: 10.1093/intqhc/mzq066. Epub 2010 Nov 16.
To reduce the probability of failure in the oral chemotherapy order, review and administration process and to reduce oral chemotherapy-related prescribing errors intercepted by clinical pharmacists prior to reaching the patient.
A before-and-after cohort study.
A 719-bed multidisciplinary tertiary care institution with a pediatric division and an outpatient cancer center.
A multidisciplinary team characterized key elements of the oral chemotherapy process using healthcare failure modes and effects analysis (HFMEA).
INTERVENTION(S): Oral chemotherapy computerized provider order entry (CPOE) was developed and implemented.
MAIN OUTCOME MEASURE(S): Pharmacist-intercepted oral chemotherapy prescribing errors over a 24-month period (before) and over a 6-month period (after) were analyzed according to the error type (errors in clinical decision making, errors in transcription or errors related to prescribing policy). The incidence of prescribing errors prior to and following CPOE implementation was compared by calculating the odds ratio (OR) and the 95% confidence interval (CI).
HFMEA hazard analysis revealed seven potential failure modes, with the highest hazard scores in the prescribing and administration components of the process. CPOE implementation significantly (P= 0.023) reduced prescribing error risk by 69% [OR (95% CI) = 0.31 (0.11-0.86)] and eliminated certain types of errors that can lead to significant patient harm.
Prescribing oral chemotherapy is a failure mode with significant risk of inducing patient harm. CPOE is effective in reducing prescribing errors of oral chemotherapy and should be considered part of a fail-safe process to improve safety.
降低口服化疗医嘱、审核和给药流程失败的概率,减少临床药师在医嘱到达患者之前拦截的与口服化疗相关的用药错误。
前后对照队列研究。
一家拥有儿科分部和门诊癌症中心的 719 张床位的多学科三级保健机构。
多学科团队使用医疗保健失效模式与效应分析(HFMEA)确定口服化疗流程的关键要素。
开发并实施了口服化疗计算机化医嘱录入(CPOE)。
在 24 个月(之前)和 6 个月(之后)的时间内,根据错误类型(临床决策错误、转录错误或与用药政策相关的错误)分析药师拦截的口服化疗用药错误。通过计算比值比(OR)和 95%置信区间(CI),比较 CPOE 实施前后的用药错误发生率。
HFMEA 危害分析显示了七种潜在的失效模式,其中流程中开方和给药环节的危害评分最高。CPOE 的实施显著(P=0.023)降低了 69%的用药错误风险[OR(95%CI)=0.31(0.11-0.86)],并消除了某些可能导致严重患者伤害的错误类型。
开具口服化疗医嘱是一种具有显著患者伤害风险的失效模式。CPOE 可有效减少口服化疗的用药错误,应被视为提高安全性的故障安全流程的一部分。